Telesis Bio, Inc. (TBIO)
NASDAQ: TBIO · IEX Real-Time Price · USD
0.440
+0.010 (2.30%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Telesis Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019
Revenue
27.4411.046.584.81
Revenue Growth (YoY)
148.44%67.93%36.86%-
Cost of Revenue
11.846.742.952.68
Gross Profit
15.64.33.632.13
Selling, General & Admin
38.6225.2111.065.79
Research & Development
23.4614.478.933.32
Other Operating Expenses
0.030.060.070
Operating Expenses
62.1139.7420.069.1
Operating Income
-46.51-35.44-16.44-6.98
Interest Expense / Income
1.221.370.691.49
Other Expense / Income
0.722.140.88-0.16
Pretax Income
-48.45-38.94-18.01-8.3
Income Tax
0.020.010.010
Net Income
-48.47-38.96-18.01-8.3
Shares Outstanding (Basic)
2918515
Shares Outstanding (Diluted)
2918515
Shares Change
61.69%264.34%-66.66%-
EPS (Basic)
-1.65-2.14-3.60-0.55
EPS (Diluted)
-1.65-2.14-3.60-0.55
Free Cash Flow
-43.18-38.55-15.59-6.47
Free Cash Flow Per Share
-1.47-2.12-3.12-0.43
Gross Margin
56.84%38.93%55.12%44.29%
Operating Margin
-169.53%-320.89%-249.92%-145.18%
Profit Margin
-176.68%-352.78%-273.87%-172.78%
Free Cash Flow Margin
-157.40%-349.11%-237.00%-134.63%
EBITDA
-44.36-36-15.86-5.96
EBITDA Margin
-161.67%-326.01%-241.15%-123.93%
Depreciation & Amortization
2.881.571.460.86
EBIT
-47.23-37.58-17.32-6.81
EBIT Margin
-172.15%-340.26%-263.31%-141.77%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).